Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025

Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025

Q3 revenues increased by 18% to $27.4 million
Adjusted EBITDA profitability of $1.0 million for Q3
Acquisition of ExoDx business from Bio-Techne Corporation
Conference call with Q&A today at 4:30 PM ET / 22:30 CET

Read more at globenewswire.com